The Royal Marsden Cancer Charity hails Sheikha Jawaher Al Qasimi’s role in advancing precision medicine for cancer treatment

The Sharjah Clinical Genomics Laboratory in the UK is advancing research and bringing hope to thousands of cancer patients A humanitarian initiative by HH Sheikha Jawaher Al Qasimi, the lab was established with a £500,000 donation One of only two UK labs selected by NHS England to evaluate long-read whole genome sequencing for clinical application. … Continue reading The Royal Marsden Cancer Charity hails Sheikha Jawaher Al Qasimi’s role in advancing precision medicine for cancer treatment

Memorial Sloan Kettering Cancer Center Ranked as the Best Cancer Center in the Northeast U.S. and New York, Second in the Nation, and First for Urology Care by U.S. News & World Report

Middle East, 11August 2025:Memorial Sloan Kettering Cancer Center (MSK), a global leader in cancer care and research, has been recognized as the best cancer center in the Northeast United States and New York, the number two hospital for cancer care in the United States, and the number one hospital nationally for urology care by U.S. … Continue reading Memorial Sloan Kettering Cancer Center Ranked as the Best Cancer Center in the Northeast U.S. and New York, Second in the Nation, and First for Urology Care by U.S. News & World Report

Years of pain, one breakthrough: Emirati man spared lifetime of incontinence after UAE’s first endoscopic rectal tumour removal

38-year-Old Emirati man suffering for years with pain and bleeding gets groundbreaking procedure  Dubai – August 11, 2025:Medcare Royal Specialty Hospital has achieved a global medical milestone, successfully performing the first-ever full-thickness endoscopic rectal tumor removal followed by advanced endoscopic hand suturing. This ultra-complex procedure, carried out by Dr. Mohamed Abdelhafez, Head of the Gastroenterology … Continue reading Years of pain, one breakthrough: Emirati man spared lifetime of incontinence after UAE’s first endoscopic rectal tumour removal

Eyestem Raises Funds to Advance Eyecyte-RPE™ Through Phase 2 Clinical Trial and Towards US IND

India, 11th August 2025: Eyestem Research Pvt Ltd has raised funds in a significantly oversubscribed funding round to support the next stage of development for its investigational retinal pigment epithelial (RPE) cell therapy, Eyecyte-RPE™. The capital will enable completion of the ongoing Phase 2 clinical trial in India and support preparations for filing an Investigational … Continue reading Eyestem Raises Funds to Advance Eyecyte-RPE™ Through Phase 2 Clinical Trial and Towards US IND

Burjeel Holdings Reports 129% IncreaseQ2’25 Net Profit, with Accelerated Revenue Growth

Revenue +18.7%Revenue accelerated to AED 1,403 million, driven by strong patient footfall and improved yield from high-value services. EBITDA +59.4%EBITDA increased to AED 306 million, supported by top-line growth and continued cost efficiencies. Net Profit+128.9%Net profit reached AED 148 million, reflecting strong margin expansion and gains from asset optimization. Patients +12.1%Patient footfall increased, fueled by expanding demand … Continue reading Burjeel Holdings Reports 129% IncreaseQ2’25 Net Profit, with Accelerated Revenue Growth